Self-reported food allergies (FAs) affect approximately 8% of the US pediatric and approximately 10% of the adult population, which reflects potentially disproportionate increases among ethnically and racially minoritized groups. Multiple gaps and unmet needs exist regarding FA disparities. There is reported evidence of disparities in FA outcomes, and the FA burden may also be disproportionate in low-income families. Low family income has been associated with higher emergency care spending and insecure access to allergen-free food. Pharmacoinequity arises in part as a result of structural racism still experienced by historically marginalized populations today. Historically redlined communities continue to experience greater rates of neighborhood-level air pollution and indoor allergen exposure, lack of transportation to medical appointments, poverty, and lower prescription rates of necessary medications. Clinical research needs racially and ethnically diverse participation to ensure generalizability of research findings and equitable access to medical advances, but race reporting in clinical trials has been historically poor. Addressing health disparities in FA is a priority of clinical care, with professional organizations such as the American Academy of Allergy, Asthma & Immunology having a prominent role to play in mitigating the challenges faced by these individuals. In this position statement we recommend some key steps to address this important issue.

中文翻译：

---

解决食物过敏中的健康差异：AAAAI 事先授权工作组的立场声明。


自我报告的食物过敏 （FAs） 影响了大约 8% 的美国儿科和大约 10% 的成年人口，这反映了少数族裔和种族群体中可能不成比例的增加。关于 FA 差异存在多重差距和未满足的需求。据报道，FA 结果存在差异，并且 FA 负担在低收入家庭中也可能不成比例。低家庭收入与较高的紧急护理支出和无法获得无过敏原的食物有关。药物不平等的部分原因是今天历史上被边缘化的人群仍然存在结构性种族主义。历史上被划为红线的社区继续经历更高的社区空气污染和室内过敏原暴露率、缺乏去看病的交通工具、贫困和必要药物的处方率较低。临床研究需要种族和民族多样化的参与，以确保研究结果的普遍性和公平获得医学进步，但临床试验中的种族报告历来很差。解决FA中的健康差异是临床护理的优先事项，像美国过敏、哮喘和免疫学会这样的专业组织在缓解这些个体面临的挑战中起着突出的作用。在本立场声明中，我们建议采取一些关键步骤来解决这一重要问题。